top of page
Research & Development Pipeline
RS Oncology’s development pipeline was initiated in early 2022 with the phase 1/2 MITOPE clinical trial
bottom of page
RS Oncology’s development pipeline was initiated in early 2022 with the phase 1/2 MITOPE clinical trial